Abstract
Over-expression studies have demonstrated that RALT (receptor associated late transducer) is a feedback inhibitor of ErbB-2 mitogenic and transforming signals. In growth-arrested cells, expression of endogenous RALT is induced by mitogenic stimuli, is high throughout mid to late G1 and returns to baseline as cells move into S phase. Here, we show that physiological levels of RALT effectively suppress ErbB-2 mitogenic signals. We also investigate the regulatory mechanisms that preside to the control of RALT expression. We demonstrate that pharmacological ablation of extracellular signal-regulated kinase (ERK) activation leads to blockade of RALT expression, unlike genetic and/or pharmacological interference with the activities of PKC, Src family kinases, p38 SAPK and PI-3K. Tamoxifen-dependent activation of an inducible Raf : ER chimera was sufficient to induce RALT expression. Thus, activation of the Ras–Raf–ERK pathway is necessary and sufficient to drive RALT expression. The RALT protein is labile and was found to accumulate robustly upon pharmacological inhibition of the proteasome. We were able to detect ubiquitin-conjugated RALT species in living cells, suggesting that ubiquitinylation targets RALT for proteasome-dependent degradation. Such an integrated transcriptional and post-translational control is likely to provide RALT with the ability to fluctuate timely in order to tune ErbB signals.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR . 1995 J. Biol. Chem. 270: 27489–27494
Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, Sprigg NS, Corbin JE, Cornish AL, Darwiche R, Owczarek CM, Kay TW, Nicola NA, Hertzog PJ, Metcalf D, Hilton DJ . 1999 Cell 98: 597–608
Blagosklonny MV, An WG, Melillo G, Nguyen P, Trepel JB, Neckers LM . 1999 Oncogene 18: 6460–6468
Chen C, Okayama H . 1987 Mol. Cell Biol. 7: 2745–2752
Chiariello M, Gomez E, Gutkind JS . 2000 Biochem. J. 349: 869–876
Davies SP, Reddy H, Caivano M, Cohen P . 2000 Biochem. J. 351: 95–105
Douglas DN, Fink HS, Ridgway ND, Cook HW, Byers DM . 1999 Biochim. Biophys. Acta 1448: 439–449
Fazioli F, Kim UH, Rhee SG, Molloy CJ, Segatto O, Di Fiore PP . 1991 Mol. Cell Biol. 11: 2040–2048
Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL . 1995 Science 268: 726–731
Fiorentino L, Pertica C, Fiorini M, Talora C, Crescenzi M, Castellani L, Alema S, Benedetti P, Segatto O . 2000 Mol. Cell Biol. 20: 7735–7750
Fiorini M, Alimandi M, Fiorentino L, Sala G, Segatto O . 2001 FEBS Lett. 490: 132–141
Flanagan AM, Lader CS . 1998 Curr. Opin. Hematol. 5: 181–185
Freeman M . 2000 Nature 408: 313–319
Gallo R, Provenzano C, Carbone R, Di Fiore PP, Castellani L, Falcone G, Alema S . 1997 Oncogene 15: 1929–1936
Ghiglione C, Perrimon N, Perkins LA . 1999 Dev. Biol. 205: 181–193
Greenwood S, Struhl G . 1997 Development 124: 4879–4886
Gross I, Bassit B, Benezra M, Licht JD . 2001 J. Biol. Chem. 276: 46460–46468
Hackel PO, Gishizky M, Ullrich A . 2001 Biol. Chem. 382: 1649–1662
Harari D, Yarden Y . 2000 Oncogene 19: 6102–6114
Hochstrasser M . 1996 Annu. Rev. Genet. 30: 405–439
Huggins GS, Chin MT, Sibinga NE, Lee SL, Haber E, Lee ME . 1999 J. Biol. Chem. 274: 28690–28696
Hughes EA, Ortmann B, Surman M, Cresswell P . 1996 J. Exp. Med. 183: 1569–1578
Impagnatiello MA, Weitzer S, Gannon G, Compagni A, Cotten M, Christofori G . 2001 J. Cell Biol. 152: 1087–1098
Jones SM, Kazlauskas A . 2001 FEBS Lett. 490: 110–116
Krebs DL, Hilton DJ . 2001 Stem Cells 19: 378–387
Latella L, Sacco A, Pajalunga D, Tiainen M, Macera D, D'Angelo M, Felici A, Sacchi A, Crescenzi M . 2001 Mol. Cell Biol. 21: 5631–5643
Lee KL, Makkinje A, Ch'Ang LY, Kenney FT . 1989 Arch. Biochem. Biophys. 269: 106–113
Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M . 1997 Nat. Med. 3: 231–234
Luttrell DK, Luttrell LM, Parsons SJ . 1988 Mol. Cell Biol. 8: 497–501
Makkinje A, Quinn DA, Chen A, Cadilla CL, Force T, Bonventre JV, Kyriakis JM . 2000 J. Biol. Chem. 275: 17838–17847
Marine JC, McKay C, Wang D, Topham DJ, Parganas E, Nakajima H, Pendeville H, Yasukawa H, Sasaki A, Yoshimura A, Ihle JN . 1999a Cell 98: 617–627
Marine JC, Topham DJ, McKay C, Wang D, Parganas E, Stravopodis D, Yoshimura A, Ihle JN . 1999b Cell 98: 609–616
Marshall CJ . 1995 Cell 80: 179–185
Marte BM, Graus-Porta D, Jeschke M, Fabbro D, Hynes NE, Taverna D . 1995a Oncogene 10: 167–175
Marte BM, Jeschke M, Graus-Porta D, Taverna D, Hofer P, Groner B, Yarden Y, Hynes NE . 1995b Mol. Endocrinol. 9: 14–23
McMahon M, Woods D . 2001 Biochim. Biophys. Acta 1471: M63–M71
Moghal N, Sternberg PW . 1999 Curr. Opin. Cell Biol. 11: 190–196
Mulcahy LS, Smith MR, Stacey DW . 1985 Nature 313: 241–243
Muthuswamy SK, Muller WJ . 1995 Oncogene 11: 1801–1810
Myung J, Kim KB, Crews CM . 2001 Med. Res. Rev. 21: 245–273
Nagao M, Kaziro Y, Itoh H . 1999 Oncogene 18: 4425–4434
Oberg C, Li J, Pauley A, Wolf E, Gurney M, Lendahl U . 2001 J. Biol. Chem. 276: 35847–35853
Ozaki K, Kadomoto R, Asato K, Tanimura S, Itoh N, Kohno M . 2001 Biochem. Biophys. Res. Commun. 285: 1084–1088
Pages G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, Pouyssegur J . 1993 Proc. Natl. Acad. Sci. USA 90: 8319–8323
Pai LM, Barcelo G, Schupbach T . 2000 Cell 103: 51–61
Palombella VJ, Rando OJ, Goldberg AL, Maniatis T . 1994 Cell 78: 773–785
Pear WS, Nolan GP, Scott ML, Baltimore D . 1993 Proc. Natl. Acad. Sci. USA 90: 8392–8396
Perrimon N, McMahon AP . 1999 Cell 97: 13–16
Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon WY, Park M . 2001 Mol. Cell 8: 995–1004
Rechsteiner M, Rogers SW . 1996 Trends Biochem. Sci. 21: 267–271
Robinson MJ, Cobb MH . 1997 Curr. Opin. Cell Biol. 9: 180–186
Rosette C, Karin M . 1996 Science 274: 1194–1197
Rountree MR, Bachman KE, Herman JG, Baylin SB . 2001 Oncogene 20: 3156–3165
Salama SR, Hendricks KB, Thorner J . 1994 Mol. Cell Biol. 14: 7953–7966
Samuels ML, Weber MJ, Bishop JM, McMahon M . 1993 Mol. Cell Biol. 13: 6241–6252
Sasaki A, Taketomi T, Wakioka T, Kato R, Yoshimura A . 2001 J. Biol. Chem. 276: 36804–36808
Schafer C, Ross SE, Bragado MJ, Groblewski GE, Ernst SA, Williams JA . 1998 J. Biol. Chem. 273: 24173–24180
Schlessinger J . 2000 Cell 103: 211–225
Simon MA . 2000 Cell 103: 13–15
Spataro V, Norbury C, Harris AL . 1998 Br. J. Cancer 77: 448–455
Vlahos CJ, Matter WF, Hui KY, Brown RF . 1994 J. Biol. Chem. 269: 5241–5248
Wallace AD, Cidlowski JA . 2001 J. Biol. Chem. 276: 42714–42721
Waterman H, Yarden Y . 2001 FEBS Lett. 490: 142–152
Wick M, Burger C, Funk M, Muller R . 1995 Exp. Cell Res. 219: 527–535
Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M . 1997 Mol. Cell Biol. 17: 5598–5611
Xu J, Attisano L . 2000 Proc. Natl. Acad. Sci. USA 97: 4820–4825
Yarden Y, Sliwkowski MX . 2001 Nat. Rev. Mol. Cell Biol. 2: 127–137
Yoon CH, Lee J, Jongeward GD, Sternberg PW . 1995 Science 269: 1102–1105
Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG . 2001 Nat. Genet. 28: 29–35
Zhu J, Woods D, McMahon M, Bishop JM . 1998 Genes Dev. 12: 2997–3007
Acknowledgements
This paper is dedicated to the cherished memory of our friend and colleague Franco Tatò. We are indebted to B Berk, D Bohmann, N Canu, M Crescenzi, CJ Marshall, M McMahon, J Han, L Parada and H Paterson for providing reagents. We thank C Full and R Fraioli for expert technical assistance. M Fiorini is the recipient of an AIRC post-doctoral fellowship. O Segatto is supported by AIRC; S Alemà acknowledges the support of AIRC and CNR-PF-Biotecnologie.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fiorini, M., Ballarò, C., Sala, G. et al. Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control. Oncogene 21, 6530–6539 (2002). https://doi.org/10.1038/sj.onc.1205823
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205823
Keywords
This article is cited by
-
Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand
Cell Death & Disease (2018)
-
MIG-6 negatively regulates STAT3 phosphorylation in uterine epithelial cells
Oncogene (2018)
-
Upregulation of mitogen-inducible gene 6 triggers antitumor effect and attenuates progesterone resistance in endometrial carcinoma cells
Cancer Gene Therapy (2015)
-
Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6
Nature Structural & Molecular Biology (2015)
-
A pervasive role for MIG6 in restraining cell proliferation
Cell Death & Differentiation (2014)